Researchers from the University of Michigan conducted a study that suggests that by using a chip to process blood samples, doctors can monitor the amount of cancer cells in a patient’s blood to determine how well a treatment is working by the fourth week. Access to this data would allow clinicians to adapt cancer treatments to patients on an individual level.
Join us Sept. 14 at the U-M Golf Course for the 2024 Alumni Territory Homecoming Tailgate!